Sernova Corp. | WebDisclosure

BRIEF

published on 09/27/2024 at 12:47, 2 months 24 days ago

Sernova Corp: First Berlin Equity Research Maintains Buy Rating

BUY Rating Sernova Corp Clinical Trial Type 1 Diabetes Cell Pouch
BRIEF

published on 09/27/2024 at 12:47, 2 months 24 days ago

Sernova Corp : First Berlin Equity Research maintient sa note d'achat

Sernova Corp Essai Clinique Acheter Une Note Diabète De Type 1 Pochette Pour Cellule
PRESS RELEASE

published on 09/27/2024 at 12:42, 2 months 24 days ago

Original-Research: Sernova Corp (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reaffirms Buy rating for Sernova Corp (ISIN: CA81732W1041) with updated price target of CAD1.90 following positive results in treating type 1 diabetes

First Berlin Equity Research BUY Rating Sernova Corp Type 1 Diabetes CAD1.90
PRESS RELEASE

published on 02/06/2024 at 15:02, 10 months 15 days ago

Original-Research: Sernova Corp (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research has reiterated its BUY rating and CAD 3.80 price target for Sernova Corp (ISIN: CA81732W1041) based on the company's financial statement release and business update for FY 22/23. Sernova's achievements in diabetes treatment and potential partnering deal are anticipated to drive stock performance

First Berlin Equity Research Sernova Corp FY 22/23 Diabetes Treatment Partnering Deal
PRESS RELEASE

published on 10/19/2023 at 15:57, 1 year 2 months ago

Original-Research: Sernova Corp (von First Berlin Equity Research GmbH): BUY
PRESS RELEASE

published on 09/14/2023 at 22:06, 1 year 3 months ago

Sernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September 22
PRESS RELEASE

published on 09/13/2023 at 13:01, 1 year 3 months ago

Sernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business Update
PRESS RELEASE

published on 05/03/2023 at 13:01, 1 year 7 months ago

Sernova Announces Research Collaboration with AstraZeneca to Evaluate Novel Potential Therapeutic Cell Applications
PRESS RELEASE

published on 04/10/2023 at 13:05, 1 year 8 months ago

Sernova to Present at 2023 Alliance for Regenerative Medicine Cell & Gene Meeting on the Med
PRESS RELEASE

published on 03/22/2023 at 12:04, 1 year 8 months ago

Sernova: Abstract on First Cohort of its Phase 1/2 Study Involving Islet Transplantation into Cell Pouch Selected for Oral Podium Presentation at American Diabetes Association 83rd Scientific Sessions

Published on 12/21/2024 at 01:30, 16 hours 42 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 16 hours 42 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 18 hours 7 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 18 hours 12 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 18 hours 42 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 17 hours 21 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 17 hours 27 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 23 hours 2 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 23 hours 16 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 5 hours 55 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 5 hours 55 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News